Serum ferritin predicts early mortality in patients with decompensated cirrhosis

Journal of Hepatology

Volumn 61, Issue 1, 2014, Pages 43-50

  Maiwall, Rakhi ^a   Kumar, Suman ^b   Chaudhary, A K ^a   Maras, Jaswinder ^a   Wani, Zeeshan ^a   Kumar, Chandan ^a   Rastogi, A ^a   Bihari, C ^a   Vashisht, Chitranshu ^a   Sarin, S K ^a  

^a INSTITUTE OF LIVER AND BILIARY SCIENCES   (India)

^b Classified Specialist   (India)

Author keywords

Decompensated cirrhosis; Ferritin; Hyperferritinemia; Mortality; Portal hypertension

Indexed keywords

ALBUMIN; ALCOHOL; BILIRUBIN; CREATININE; FERRITIN; HEMOGLOBIN; SODIUM; BIOLOGICAL MARKER;

ACUTE ON CHRONIC LIVER FAILURE; ADULT; ARTICLE; ASCITES; BACTERIAL PERITONITIS; BILIRUBIN BLOOD LEVEL; CHILD TURCOTTE SCORING SYSTEM; CHRONIC LIVER DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DECOMPENSATED LIVER CIRRHOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HEPATITIS C; HEPATORENAL SYNDROME; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; POTASSIUM BLOOD LEVEL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SCORING SYSTEM; SODIUM BLOOD LEVEL; SURVIVAL; SURVIVOR; UREA BLOOD LEVEL; AGED; BLOOD; COHORT ANALYSIS; EPIDEMIOLOGY; INDIA; KAPLAN MEIER METHOD; LIVER CIRRHOSIS; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL;

ADULT; AGED; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; FERRITINS; HUMANS; INDIA; KAPLAN-MEIER ESTIMATE; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES;

EID: 84902661883     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.03.027     Document Type: Article

References (21)

1. C.I. Bhagat, S. Fletcher, J. Joseph, and J.P. Beilby Plasma ferritin in acute hepatocellular damage Clin Chem 46 6 Pt 1 2000 885 886
2. A. Hiraoka, N. Horiike, S.M. Akbar, K. Michitaka, T. Matsuyama, and M. Onji et al. Soluble CD163 in patients with liver diseases: very high levels of soluble CD163 in patients with fulminant hepatic failure J Gastroenterol 40 2005 52 56
3. H.J. Møller, H. Gronbaek, F.V. Schiodt, P. Holland Fischer, M. Schilsky, and S. Munoz et al. Soluble CD163 from activated macrophages predicts mortality in acute liver failure J Hepatol 47 2007 671 676
4. Melanie D. Beaton, and Paul C. Adams et al. Treatment of hyperferritinemia Ann Hepatol 11 2012 294 300
5. Shira Zelber-Sagi, Dorit Nitzan-Kaluski, Zamir Halpern, and Ran Oren et al. NAFLD and hyperinsulinemia are major determinants of serum ferritin levels J Hepatol 46 2007 700 707
6. E. Bugianesi, P. Manzini, S. D'Antico, E. Vanni, F. Longo, and N. Leone et al. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver Hepatology 39 2004 179 187
7. Paola Dongiovanni, Anna Ludovica Fracanzani, Silvia Fargion, and Luca Valenti et al. Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target J Hepatol 55 2011 920 932
8. N.M. Walker, K.A. Stuart, R.J. Ryan, S. Desai, S. Saab, and J.A. Nicol et al. Serum ferritin concentration predicts mortality in patients awaiting liver transplantation Hepatology 51 5 2010 1683 1691
9. S.K. Sarin, A. Kumar, and J.A. Almeida et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver(APASL) Hepatol Int 3 1 2009 269 282
10. R. Moreau, R. Jalan, P. Gines, M. Pavesi, P. Angeli, and J. Cordoba et al. CANONIC Study Investigators of the EASL-CLIF Consortium. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis Gastroenterology 144 2013 1426 1437
11. J. Bruix, M. Sherman Practice Guidelines Committee American Association for the Study of Liver Diseases Management of hepatocellular carcinoma Hepatology 42 5 2005 1208 1236
12. V. Arroyo, P. Gines, A.L. Gerbes, F.J. Dudley, P. Gentilini, and G. Laffi et al. Definition and diagnostic criteria of refractory ascites and HRS in cirrhosis. Internation ASCITES CLUB Hepatology 23 1996 164 176
13. B.A. Runyon AASLD practice guideline: management of adult patients with ascites due to cirrhosis Hepatology 39 2004 841 856
14. P.S. Kamath, R.H. Wiesner, M. Malinchoc, W. Kremers, T.M. Therneau, and C.L. Kosberg et al. A model to predict survival in patients with end-stage liver disease Hepatology 33 2001 464 470
15. K.A. Attia, K.C. Ackoundou-N'guessan, A.T. N'dri-yoman, A.K. Mahassadi, E. Messou, and Y.F. Bathaix et al. Child-Pugh-Turcott vs. Meld score for predicting survival in a retrospective cohort of black African cirrhotic patients World J Gastroenterol 14 2008 286 291
16. J.W. Halliday, G.A. Ramm, L.W. Powell, J.H. Brock, and M.J. Pippard et al. Cellular iron processing and storage: the role of ferritin Iron metabolism in health and disease 1994 WB Saunders London p. 97-121
17. M. Worwood Laboratory determination of iron status Iron metabolism in health and disease 1994 WB Saunders London p. 449-476
18. S.J. Searle, K.J.R. Kerr, J.W. Halliday, and L.W. Powell et al. Iron storage disease R.N.M. MacSween, P.P. Anthony, P.J. Scheuer, A.D. Burt, B.C. Portman, Pathology of the liver 1994 Churchill Livingstone Edinburgh 219 241
19. T.J. Weismüller, G.I. Kirchner, M.N. Scherer, A.A. Negm, A.A. Schnitzbauer, and F. Lehner et al. Serum ferritin concentration and transferrin saturation before liver transplantation predict decreased long-term recipient survival Hepatology 54 6 2011 2114 2124
20. S.K. Moestrup, and H.J. Møller CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response Ann Med 36 2004 347 354
21. G.P. Kaushal, and S.V. Shah Challenges and advances in the treatment of AKI J Am Soc Nephrol 2014 [Epub ahead of print]